71 related articles for article (PubMed ID: 29156868)
1. A nationwide evaluation of off-label drug utilization in Turkey.
Özdamar EN; Akıcı A; Alkan A; Bayar B; Gürsöz H
Turk J Med Sci; 2017 Aug; 47(4):1229-1238. PubMed ID: 29156868
[TBL] [Abstract][Full Text] [Related]
2. Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data.
Akıcı N; Kırmızı Nİ; Aydın V; Bayar B; Aksoy M; Akıcı A
Turk J Pediatr; 2020; 62(6):949-961. PubMed ID: 33372433
[TBL] [Abstract][Full Text] [Related]
3. Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey.
Kırmızı Nİ; Aydın V; Akıcı N; Bayar B; Akıcı A
Turk J Med Sci; 2021 Aug; 51(4):1791-1799. PubMed ID: 33600094
[TBL] [Abstract][Full Text] [Related]
4. [Situation analysis of off-label drug use in China].
Rui-Xue HU; Mei MO; Dan-Dan YU; Hui-Min LI; Xing L; Xiao-Jiao D; Yu-Bo G
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4277-4284. PubMed ID: 33164415
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clinical trials and off-label drug use in hospitalized pediatric patients.
Roldán T; Villamañán E; Ruano M; Larrubia Y; Gómez-Salcedo P; Herrero A
Arch Argent Pediatr; 2014 Jun; 112(3):249-53. PubMed ID: 24862807
[TBL] [Abstract][Full Text] [Related]
6. Drug use evaluation of tamoxifen focusing on off-label use in a managed care population in Israel.
Kahan NR; Waitman DA; Blackman S; Vardy DA
J Manag Care Pharm; 2010 Jun; 16(5):355-9. PubMed ID: 20518588
[TBL] [Abstract][Full Text] [Related]
7. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
8. Off-label use of medicines in paediatric inpatients at an Australian teaching hospital.
Ballard CD; Peterson GM; Thompson AJ; Beggs SA
J Paediatr Child Health; 2013 Jan; 49(1):38-42. PubMed ID: 23279160
[TBL] [Abstract][Full Text] [Related]
9. Trends in off-label beta-blocker use: a secondary data analysis.
Lin HW; Phan K; Lin SJ
Clin Ther; 2006 Oct; 28(10):1736-46; discussion 1710-1. PubMed ID: 17157130
[TBL] [Abstract][Full Text] [Related]
10. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
11. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
[TBL] [Abstract][Full Text] [Related]
12. Off-label utilization of antihypertensive medications in children.
Yoon EY; Dombkowski KJ; Rocchini A; Lin JJ; Davis MM
Ambul Pediatr; 2007; 7(4):299-303. PubMed ID: 17660101
[TBL] [Abstract][Full Text] [Related]
13. Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.
Mohamad NF; Mhd Ali A; Mohamed Shah N
Int J Clin Pharm; 2015 Feb; 37(1):127-32. PubMed ID: 25488318
[TBL] [Abstract][Full Text] [Related]
14. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
15. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
Kocs D; Fendrick AM
Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
[TBL] [Abstract][Full Text] [Related]
16. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
[TBL] [Abstract][Full Text] [Related]
17. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
[TBL] [Abstract][Full Text] [Related]
18. Prospective data collection of off-label use of rituximab in Australian public hospitals.
O'Connor K; Liddle C
Intern Med J; 2013 Aug; 43(8):863-70. PubMed ID: 23735074
[TBL] [Abstract][Full Text] [Related]
19. Off-label prescribing among office-based physicians.
Radley DC; Finkelstein SN; Stafford RS
Arch Intern Med; 2006 May; 166(9):1021-6. PubMed ID: 16682577
[TBL] [Abstract][Full Text] [Related]
20. Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.
Yasinta M; Che RC; Hu CY; Du XH; Ding GX; Huang SM; Chen Y; Zhang AH
World J Pediatr; 2016 May; 12(2):236-42. PubMed ID: 26684307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
